Suzano and Kimberly-Clark (KMB) are set to secure unconditional EU antitrust approval for a USD 3.4bln JV, according to sources

The successful acquisition of unconditional EU antitrust approval for the USD 3.4 billion joint venture between Suzano and Kimberly-Clark is a positive signal for market sentiment, as it reduces regulatory uncertainty around the deal.

Newsquawk StaffPublished On the live feed at 6 more headlines followed before this page went public
Newsquawk headlinesUTC

US government economists estimate that pharmaceutical deals to reduce some prescription drug prices could save over USD 500bln over a 10yr period, AP reports

Newsquawk European Market Wrap - 5th May 2026

Suzano and Kimberly-Clark (KMB) are set to secure unconditional EU antitrust approval for a USD 3.4bln JV, according to sources

US RCM/TIPP Economic Optimism Index (May) 42.6 vs. Exp. 42 (Prev. 42.8)

US JOLTs Job Quits (Mar) 3.171M (Prev. 2.974M)

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This approval could lead to a more integrated operational strategy for both companies, enhancing their competitive position in the household products sector and potentially influencing stock performance. Keep an eye on how this might affect related equities and the broader industry dynamics.

Related headlines

The whole workspace, free to try.

Try it free